153 related articles for article (PubMed ID: 36638643)
1. The salience of social context, opioid antagonist use, and prior opioid exposure as determinants of fatal and non-fatal opioid overdoses.
Zimmerman GM; Douglas SD; Turchan BS; Braga AA
Health Place; 2023 Jan; 79():102970. PubMed ID: 36638643
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses.
Edvardsen HME; Aamodt C; Bogstrand ST; Krajci P; Vindenes V; Rognli EB
Br J Clin Pharmacol; 2022 Oct; 88(10):4494-4504. PubMed ID: 35470456
[TBL] [Abstract][Full Text] [Related]
3. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
4. Developing medical simulations for opioid overdose response training: A qualitative analysis of narratives from responders to overdoses.
Edwards GF; Mierisch C; Mutcheson B; Strauss A; Coleman K; Horn K; Parker SH
PLoS One; 2024; 19(3):e0294626. PubMed ID: 38547079
[TBL] [Abstract][Full Text] [Related]
5. [Fatal opioid overdoses usually occur without anyone being present and able to intervene. Knowledge of the presence of witnesses is important for how naloxone programs should be designed].
Andersson L; Johnson B
Lakartidningen; 2022 Jan; 119():. PubMed ID: 35077567
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data.
Korona-Bailey JA; Nechuta S; Golladay M; Moses J; Bastasch O; Krishnaswami S
Ann Epidemiol; 2021 Jun; 58():149-155. PubMed ID: 33744415
[TBL] [Abstract][Full Text] [Related]
7. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
Alexander GC; Ballreich J; Mansour O; Dowdy DW
Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
[TBL] [Abstract][Full Text] [Related]
8. Zimhi - a higher-dose injectable naloxone for opioid overdose.
Med Lett Drugs Ther; 2022 Apr; 64(1648):61-62. PubMed ID: 35436775
[No Abstract] [Full Text] [Related]
9. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
Kelty E; Hulse G
Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
[TBL] [Abstract][Full Text] [Related]
10. Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder.
Thylstrup B; Seid AK; Tjagvad C; Hesse M
Drug Alcohol Depend; 2020 Jan; 206():107714. PubMed ID: 31753733
[TBL] [Abstract][Full Text] [Related]
11. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
Abouk R; Pacula RL; Powell D
JAMA Intern Med; 2019 Jun; 179(6):805-811. PubMed ID: 31058922
[TBL] [Abstract][Full Text] [Related]
12. City streetscapes and neighborhood characteristics of fatal opioid overdoses among people experiencing homelessness who use drugs in New York City, 2017-2019.
Nesoff ED; Wiebe DJ; Martins SS
Int J Drug Policy; 2022 Dec; 110():103904. PubMed ID: 36370513
[TBL] [Abstract][Full Text] [Related]
13. The association between community social vulnerability and prescription opioid availability with individual opioid overdose.
El Ibrahimi S; Hendricks MA; Little K; Ritter GA; Flores D; Loy B; Wright D; Weiner SG
Drug Alcohol Depend; 2023 Nov; 252():110991. PubMed ID: 37862877
[TBL] [Abstract][Full Text] [Related]
14. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study.
Antoniou T; Men S; Tadrous M; Leece P; Munro C; Gomes T
Drug Alcohol Depend; 2022 Jul; 236():109473. PubMed ID: 35523113
[TBL] [Abstract][Full Text] [Related]
15. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
[No Abstract] [Full Text] [Related]
16. Circumstances surrounding non-fatal opioid overdoses attended by ambulance services.
Madah-Amiri D; Clausen T; Myrmel L; Brattebø G; Lobmaier P
Drug Alcohol Rev; 2017 May; 36(3):288-294. PubMed ID: 28036135
[TBL] [Abstract][Full Text] [Related]
17. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
18. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
[TBL] [Abstract][Full Text] [Related]
19. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.
Taylor M; Pradhan A; Ogando YM; Shaya F
Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459
[No Abstract] [Full Text] [Related]
20. Insights from biosurveillance: non-fatal opioid overdoses in Rhode Island 2019-21.
King E; Marchetti L; Weidele H; Wolanski J; Shrestha N; St John K; Scagos R
Addiction; 2022 Sep; 117(9):2464-2470. PubMed ID: 35434861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
